Release 5 Preview #1

This page is part of the FHIR Specification (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3 R2

4.3.15.252 HL7 Version 2 Table 0252

Vocabulary

Work Group

Maturity Level: N/A

External

Use Context: Any

This is a table defined as part of HL7 v2 .

Summary

Code System URL: http://terminology.hl7.org/CodeSystem/v2-0252

Value Set URL: http://terminology.hl7.org/ValueSet/v2-0252

Version: 2.9

Name: v2.0252

Title: v2 Causality Observations

Definition:

FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)

OID: ??

CodeSystem Resource XML / JSON

ValueSet Resource XML / JSON

Note: V2 code systems may or may not be case sensitive. V2 Code systems will have the CodeSystem.caseSensitive correctly populated in a future version of this specification.

This value set is not currently used

This code system http://terminology.hl7.org/CodeSystem/v2-0252 defines the following codes:

Code	Display	Definition	Version
AW	en: Abatement of event after product withdrawn nl: Vermindering gebeurtenis na terugtrekken product		added v2.3
BE	en: Event recurred after product reintroduced nl: Gebeurtenis trad opnieuw op na herintroductie product		added v2.3
DR	en: Dose response observed nl: Dosis reactie geobserveerd		added v2.3
EX	en: Alternative explanations for the event available nl: Alternatieve verklaringen voor gebeurtenis beschikbaar		added v2.3
IN	en: Event occurred after product introduced nl: Gebeurtenis trad op na introductie product		added v2.3
LI	en: Literature reports association of product with event nl: Literatuur vermeldt koppeling van product met gebeurtenis		added v2.3
OE	en: Occurrence of event was confirmed by objective evidence nl: Optreden van gebeurtenis is bevestigd door objectief bewijs		added v2.3
OT	en: Other nl: Anders		added v2.3
PL	en: Effect observed when patient receives placebo nl: Effect geobserveerd wanneer patiënt placebo krijgt		added v2.3
SE	en: Similar events in past for this patient nl: Vergelijkbare gebeurtenissen in verleden voor deze patiënt		added v2.3
TC	en: Toxic levels of product documented in blood or body fluids nl: Toxische niveaus van product gedocumenteerd in bloed of lichaamssappen		added v2.3

This code system http://terminology.hl7.org/CodeSystem/v2-0252 defines the following codes:

Code	Display	Definition	Version
AW	Abatement of event after product withdrawn		added v2.3
BE	Event recurred after product reintroduced		added v2.3
DR	Dose response observed		added v2.3
EX	Alternative explanations for the event available		added v2.3
IN	Event occurred after product introduced		added v2.3
LI	Literature reports association of product with event		added v2.3
OE	Occurrence of event was confirmed by objective evidence		added v2.3
OT	Other		added v2.3
PL	Effect observed when patient receives placebo		added v2.3
SE	Similar events in past for this patient		added v2.3
TC	Toxic levels of product documented in blood or body fluids		added v2.3

Dit code systeem http://terminology.hl7.org/CodeSystem/v2-0252 definieert de volgende codes:

Code	Display	Definition	Versie
AW	Vermindering gebeurtenis na terugtrekken product		added v2.3
BE	Gebeurtenis trad opnieuw op na herintroductie product		added v2.3
DR	Dosis reactie geobserveerd		added v2.3
EX	Alternatieve verklaringen voor gebeurtenis beschikbaar		added v2.3
IN	Gebeurtenis trad op na introductie product		added v2.3
LI	Literatuur vermeldt koppeling van product met gebeurtenis		added v2.3
OE	Optreden van gebeurtenis is bevestigd door objectief bewijs		added v2.3
OT	Anders		added v2.3
PL	Effect geobserveerd wanneer patiënt placebo krijgt		added v2.3
SE	Vergelijkbare gebeurtenissen in verleden voor deze patiënt		added v2.3
TC	Toxische niveaus van product gedocumenteerd in bloed of lichaamssappen		added v2.3